Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-01 08:51 am Purchase | 2026-03-31 | 13G | PACIRA BIOSCIENCES INC PCRX | Vanguard Portfolio Management | 2,585,964 6.380% | 2,585,964 (New Position) | Filing History |
| 2026-05-01 08:39 am Purchase | 2026-03-31 | 13G | PACIRA BIOSCIENCES INC PCRX | VANGUARD CAPITAL MANAGEMENT LLC | 2,088,291 5.150% | 2,088,291 (New Position) | Filing History |
| 2026-04-09 1:42 pm Purchase | 2026-03-31 | 13G | PACIRA BIOSCIENCES INC PCRX | DIMENSIONAL FUND ADVISORS LP | 2,060,597 5.100% | 2,060,597 (New Position) | Filing History |
| 2026-03-27 11:22 am Sale | 2026-03-13 | 13G | PACIRA BIOSCIENCES INC PCRX | VANGUARD GROUP INC | 0 0.000% | -5,098,424 (Position Closed) | Filing History |
| 2026-03-12 7:57 pm Unchanged | 2026-03-11 | 13D | PACIRA BIOSCIENCES INC PCRX | Doma Perpetual Capital Management LLC | 2,936,794 7.300% | 0 (Unchanged) | Filing History |
| 2026-01-02 12:18 pm Unchanged | 2025-12-30 | 13D | PACIRA BIOSCIENCES INC PCRX | Doma Perpetual Capital Management LLC | 2,936,794 6.830% | 0 (Unchanged) | Filing History |
| 2025-11-13 2:29 pm Sale | 2025-07-01 | 13G | PACIRA BIOSCIENCES INC PCRX | Renaissance Technologies LLC | 2,138,201 4.980% | -257,400 (-10.74%) | Filing History |
| 2025-11-10 8:00 pm Purchase | 2025-11-06 | 13D | PACIRA BIOSCIENCES INC PCRX | Doma Perpetual Capital Management LLC | 2,936,794 6.830% | 238,176 (+8.83%) | Filing History |
| 2025-08-13 4:11 pm Purchase | 2025-04-08 | 13G | PACIRA BIOSCIENCES INC PCRX | Renaissance Technologies LLC | 2,395,601 5.340% | 546,404 (+29.55%) | Filing History |
| 2025-08-08 1:26 pm Purchase | 2025-08-01 | 13D | PACIRA BIOSCIENCES INC PCRX | Doma Perpetual Capital Management LLC | 2,698,618 5.700% | 2,698,618 (New Position) | Filing History |
| 2025-05-02 11:16 am Sale | 2025-03-31 | 13G | PACIRA BIOSCIENCES INC PCRX | Pacer Advisors Inc. | 601,668 1.280% | -2,661,169 (-81.56%) | Filing History |
| 2025-05-02 10:44 am Purchase | 2024-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | Pacer Advisors Inc. | 3,262,837 6.930% | 3,262,837 (New Position) | Filing History |
| 2025-04-28 12:17 pm Sale | 2025-03-31 | 13G | PACIRA BIOSCIENCES INC PCRX | BlackRock, Inc. BLK | 7,017,119 15.200% | -1,096,595 (-13.52%) | Filing History |
| 2025-04-21 4:00 pm Sale | 2025-03-31 | 13G | PACIRA BIOSCIENCES INC PCRX | Millennium Management LLC | 345,625 0.700% | -1,992,744 (-85.22%) | Filing History |
| 2025-01-15 4:30 pm Purchase | 2025-01-10 | 13G | PACIRA BIOSCIENCES INC PCRX | Millennium Management LLC | 2,338,369 5.100% | 2,338,369 (New Position) | Filing History |
| 2024-02-13 5:12 pm Purchase | 2023-12-29 | 13G | PACIRA BIOSCIENCES INC PCRX | VANGUARD GROUP INC | 5,098,424 10.980% | 173,229 (+3.52%) | Filing History |
| 2024-01-19 2:40 pm Purchase | 2023-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | BlackRock, Inc. BLK | 8,113,714 17.500% | 862,806 (+11.90%) | Filing History |
| 2023-02-14 1:31 pm Sale | 2022-12-30 | 13G | PACIRA BIOSCIENCES INC PCRX | MACQUARIE GROUP LTD | 2,037,049 4.440% | -2,168,473 (-51.56%) | Filing History |
| 2023-02-09 11:30 am Purchase | 2022-12-30 | 13G | PACIRA BIOSCIENCES INC PCRX | VANGUARD GROUP INC | 4,925,195 10.730% | 259,240 (+5.56%) | Filing History |
| 2023-01-23 3:52 pm Purchase | 2022-12-31 | 13G | PACIRA BIOSCIENCES INC PCRX | BlackRock, Inc. BLK | 7,250,908 15.800% | 429,390 (+6.29%) | Filing History |